Disease-modifying drugs for Alzheimer disease: implications for people in Canada.

Watt, Jennifer A; Isaranuwatchai, Wanrudee; Grossman, Linda; Straus, Sharon E

Watt, Jennifer A; Isaranuwatchai, Wanrudee; Grossman, Linda; Straus, Sharon E.

Affiliation

Watt JA; Knowledge Translation Program (Watt, Isaranuwatchai, Straus), Li Ka Shing Knowledge Institute, St. Michael's Hospital; Division of Geriatric Medicine (Watt, Straus), Department of Medicine, University of Toronto, Toronto, Ont.; Health Intervention and Technology Assessment Program (Isaranuwatchai),
Isaranuwatchai W; Knowledge Translation Program (Watt, Isaranuwatchai, Straus), Li Ka Shing Knowledge Institute, St. Michael's Hospital; Division of Geriatric Medicine (Watt, Straus), Department of Medicine, University of Toronto, Toronto, Ont.; Health Intervention and Technology Assessment Program (Isaranuwatchai),
Grossman L; Knowledge Translation Program (Watt, Isaranuwatchai, Straus), Li Ka Shing Knowledge Institute, St. Michael's Hospital; Division of Geriatric Medicine (Watt, Straus), Department of Medicine, University of Toronto, Toronto, Ont.; Health Intervention and Technology Assessment Program (Isaranuwatchai),
Straus SE; Knowledge Translation Program (Watt, Isaranuwatchai, Straus), Li Ka Shing Knowledge Institute, St. Michael's Hospital; Division of Geriatric Medicine (Watt, Straus), Department of Medicine, University of Toronto, Toronto, Ont.; Health Intervention and Technology Assessment Program (Isaranuwatchai),

CMAJ ; 195(42): E1446-E1448, 2023 10 30.

Article in En | MEDLINE | ID: mdl-37903526

Subject(s)

Alzheimer Disease; Humans; Alzheimer Disease/drug therapy; Canada

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Limits: Humans Country/Region as subject: America do norte Language: En Journal: CMAJ Journal subject: MEDICINA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google